{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/urinary-tract-infection-lower-women/management/uti-with-catheter-no-haematuria/","result":{"pageContext":{"chapter":{"id":"07efc80a-4963-5037-a8f2-c5b63d298205","slug":"uti-with-catheter-no-haematuria","fullItemName":"Scenario: UTI with catheter  no haematuria","depth":2,"htmlHeader":"<!-- begin field 29395ecb-060d-4403-810a-a71b00f359c7 --><h2>Scenario: Suspected urinary tract infection without haematuria in non-pregnant women with an indwelling urinary catheter</h2><!-- end field 29395ecb-060d-4403-810a-a71b00f359c7 -->","summary":"Covers the management of lower urinary tract infection in non-pregnant women with an indwelling urinary catheter.","htmlStringContent":"<!-- begin item 763bffb0-20a3-40c2-8636-a71b00f35ae6 --><!-- begin field 130db2c1-040b-43f3-b8e0-acbd0084e68b --><p>From age 16 years onwards (Female).</p><!-- end field 130db2c1-040b-43f3-b8e0-acbd0084e68b --><!-- end item 763bffb0-20a3-40c2-8636-a71b00f35ae6 -->","topic":{"id":"4205a2dd-1d74-53f2-90f4-5239307d2883","topicId":"7e36f7cd-e707-44db-a683-f4197a84b187","topicName":"Urinary tract infection (lower) - women","slug":"urinary-tract-infection-lower-women","lastRevised":"Last revised in October 2020","chapters":[{"id":"96f75303-a8ae-50a0-9d5c-e5a9b96e67f1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"cafb451d-db29-558a-a6cc-20d82dde3df9","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"14a65465-7aa4-5024-bb53-b3b2099b526a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"7b90ea0f-0f86-5457-965d-930656bd2f02","slug":"changes","fullItemName":"Changes"},{"id":"4f3fd7bc-437b-509c-9a2d-5318de2b1e8b","slug":"update","fullItemName":"Update"}]},{"id":"850e1193-41eb-50b7-b401-ac0396c6e585","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"18c79474-b4ac-50cd-801a-3738d79a1159","slug":"goals","fullItemName":"Goals"},{"id":"24f4bdf7-0aa4-5f6b-a117-2c3a7da00984","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6b590746-634f-5a0c-b995-5f98bd9c6f0d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4c2be4f2-9e65-53d3-8ff6-7534932e7dc6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"835cf60d-f7b4-57b8-97ee-607930381034","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a526f295-371c-52d5-bd46-93333947aade","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"28adde3c-64d3-5e21-8797-08c56ab570c5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"4a732f85-1f37-5288-a872-611c3528c53e","slug":"definition","fullItemName":"Definition"},{"id":"8e922399-2c9d-5777-9660-944733f631f5","slug":"causes","fullItemName":"Causes"},{"id":"8fa46cfc-d97b-5218-847f-9553a7ce2854","slug":"prevalence","fullItemName":"Prevalence"},{"id":"c9ad7aa8-f54d-55a8-b6f1-804d616de2b4","slug":"prognosis","fullItemName":"Prognosis"},{"id":"a176b8d4-1d8f-5f62-935e-4f6fc4696153","slug":"complications","fullItemName":"Complications"}]},{"id":"03286f6f-e3d8-5889-8453-1db9ffb07914","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ec9700ef-7ba2-524e-868a-3dc60b345625","slug":"when-to-suspect-uti","fullItemName":"When to suspect UTI"},{"id":"182ae581-d75a-507d-8146-e0d7d26dcad8","slug":"assessment","fullItemName":"Assessment"},{"id":"5dfac6cd-ec1e-5d54-98a4-a65cf57457d9","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"6d45128d-30db-5879-917a-4a6e682fa7e9","fullItemName":"Management","slug":"management","subChapters":[{"id":"a72789b5-d51e-5516-8ab1-942aae1e0fe8","slug":"uti-no-visible-haematuria-not-pregnant-or-catheterized","fullItemName":"Scenario: UTI  (no visible haematuria, not pregnant or catheterized)"},{"id":"91dbd4da-8761-5e78-9eb2-a773cc7d2764","slug":"uti-with-visible-or-non-visible-haematuria","fullItemName":"Scenario: UTI  with visible or non-visible haematuria"},{"id":"3e093a06-3197-58a5-8c61-94586835adba","slug":"recurrent-uti-no-visible-haematuria-not-pregnant-or-catheterized","fullItemName":"Scenario: Recurrent UTI  (no visible haematuria, not pregnant or catheterized)"},{"id":"09df152e-ea9c-51c1-917c-5c4c01ab2fc8","slug":"uti-in-pregnancy-no-visible-haematuria","fullItemName":"Scenario: UTI in pregnancy  no visible haematuria"},{"id":"6d0e09de-6e28-53df-b01b-55fc899c0dd7","slug":"asymptomatic-bacteriuria-in-pregnancy","fullItemName":"Scenario: Asymptomatic bacteriuria in pregnancy"},{"id":"07efc80a-4963-5037-a8f2-c5b63d298205","slug":"uti-with-catheter-no-haematuria","fullItemName":"Scenario: UTI with catheter  no haematuria"}]},{"id":"7a32c4da-f7b1-5664-92e2-e1fdeca6361a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"b42d0bbc-d0ac-52c7-83bf-5fc7a76a38dc","slug":"trimethoprim","fullItemName":"Trimethoprim"},{"id":"76a10025-1806-5d3b-96b0-72401241a768","slug":"nitrofurantoin","fullItemName":"Nitrofurantoin"},{"id":"625120b5-8124-549f-b13c-8b37bea158ff","slug":"pivmecillinam","fullItemName":"Pivmecillinam"},{"id":"bae5a7ea-ae42-56ba-82cc-74cbc655059f","slug":"fosfomycin","fullItemName":"Fosfomycin"},{"id":"e8dc8860-ec55-59c6-96c0-805260cb7172","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"e5121975-a684-5651-bf41-c324e815c0f5","slug":"cefalexin","fullItemName":"Cefalexin"}]},{"id":"332fba52-4a32-56f0-b721-29ac73f73e6d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8f34f8fc-4bd2-54e3-87f0-a4a1394f3891","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9b392302-d709-5520-a890-25e10021e12b","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0d4bbe1a-f3f6-523c-85c0-1fae02dd5b27","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"84ca6e0f-7674-5f70-b099-406d5c783d89","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4ed139aa-715a-523d-8c0a-8f4e167d29df","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"067e363b-53be-5584-a0e9-2bf38e519877","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"045ecabb-df97-5df3-b561-ecddea4b7b17","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"6d45128d-30db-5879-917a-4a6e682fa7e9","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"87eec914-b675-5131-9cf2-e470f7b5de3d","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 5b3abe29-e4f1-46af-989e-a71b01013737 --><h3>How should I manage non-pregnant catheterized women with suspected urinary tract infection not associated with haematuria?</h3><!-- end field 5b3abe29-e4f1-46af-989e-a71b01013737 -->","summary":null,"htmlStringContent":"<!-- begin item 9bc4afd2-fbbb-4847-ba51-a71b010137ea --><!-- begin field bf99f672-b5a6-4266-a7b5-a71b01013737 --><ul><li><strong>Arrange urgent assessment in secondary care if:</strong><ul><li>There are any features of serious or systemic illness such as sepsis, pyelonephritis or if the woman is dehydrated or unable to tolerate oral fluids and drugs.</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/pyelonephritis-acute/\">Pyelonephritis - acute</a>.</li></ul></li><li><strong>Refer/seek specialist advice</strong> <strong>if the woman:</strong><ul><li>Has a higher risk of developing complications (for example has structural or functional abnormalities or a comorbid condition such as immunosuppression).</li><li>Has recurrent catheter associated-UTI (CAUTI).</li><li>Has infection caused by atypical or resistant bacteria.</li><li>Has suspected cancer — arrange an urgent 2-week wait referral.<ul><li>For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/urological-cancers-recognition-referral/\">Urological cancers - recognition and referral</a> and <a class=\"topic-reference external-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/\">Gynaecological cancers - recognition and referral</a>.</li></ul></li></ul></li><li><strong>Advise the woman on self-care measures:</strong><ul><li>Simple analgesia such as paracetamol can be used for pain relief.<ul><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a>.</li></ul></li><li>Encourage intake of enough fluids to avoid dehydration.<ul><li>Do not recommend cranberry products or urine alkalinising agents in the treatment of lower UTI.</li></ul></li><li>Patient information leaflets ‘<a data-hyperlink-id=\"7a148a21-8175-4efe-9650-a9e400e92022\" href=\"https://www.rcgp.org.uk/clinical-and-research/resources/toolkits/target-antibiotic-toolkit.aspx\" target=\"_blank\"><em>Treating your infection – Urinary tract infection (UTI)</em></a>’ and ‘<a data-hyperlink-id=\"fb9b1e17-e962-4cde-8546-a9e400e92097\" href=\"https://www.rcgp.org.uk/clinical-and-research/resources/toolkits/target-antibiotic-toolkit.aspx\" target=\"_blank\"><em>Urinary tract infections: A leaflet for older adults and carers</em></a>’ are available from the <a data-hyperlink-id=\"0a598b92-f72c-45fb-807b-a9e400e920f7\" href=\"https://www.rcgp.org.uk/\" target=\"_blank\">Royal Collage of General Practice website</a>.</li></ul></li><li><strong>If the catheter has been in place for more than 7 days:</strong><ul><li>Check for blockage and consider removing the catheter or, if this cannot be done, changing it as soon as possible — do not delay antibiotic treatment in the interim.</li><li>Before antibiotics are taken send a sample from mid-stream urine if the catheter has been removed or from the new catheter if changed — ensure the laboratory are aware of previous antibiotic use and that this is a suspected catheter associated UTI.</li></ul></li><li><strong>Offer an antibiotic:</strong><ul><li>Take account of severity of symptoms, <a class=\"topic-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/background-information/definition/\">risk of developing complications</a>, previous urine culture and susceptibility results, previous antibiotic use, and local antimicrobial resistance data.</li><li>First-choice oral antibiotic (for lower UTI symptoms only):<ul><li>Nitrofurantoin (if eGFR ≥45ml/minute) 100mg modified-release twice a day for 7 days.</li><li>Trimethoprim (if low risk of resistance) 200mg twice a day for 7 days.</li><li>Amoxicillin (only if culture results available and susceptible) 500mg three times a day for 7 days.</li></ul></li><li>Second-choice (for lower UTI symptoms only, when first-choice unsuitable):<ul><li>Pivmecillinam (a penicillin) 400mg initial dose, then 200mg three times a day for a total of 7 days.</li></ul></li><li>Be aware that nitrofurantoin and pivmecillinam are only licensed for uncomplicated lower UTIs, and are not suitable for people with upper UTI symptoms or a blocked catheter.</li><li>A summary of the National Institute for Health and Care (NICE) <a data-hyperlink-id=\"b67a2b65-9a26-4d90-b4da-a9e400e92180\" href=\"https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/antimicrobial-prescribing-guidelines\" target=\"_blank\">antimicrobial prescribing guidance</a> is available on the <a data-hyperlink-id=\"71ccdfd5-053c-4147-aac9-a9e400e92198\" href=\"http://www.nice.org.uk/\" target=\"_blank\">NICE website</a>.</li></ul></li><li><strong>Advise all women to seek urgent medical review if:</strong><ul><li>Symptoms worsen rapidly or significantly at any time or fail to improve within 48 hours of starting antibiotics — consider the possibility of <a class=\"topic-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/diagnosis/differential-diagnosis/\">alternative or serious diagnoses</a> such as pyelonephritis or sepsis.</li><li>Send a urine sample for culture and susceptibility testing (if this has not already been done) and consider treatment with another agent (as described above) while awaiting sensitivities.</li></ul></li><li><strong>Follow up urine culture and susceptibility results:</strong><ul><li>Review the choice of antibiotic when results are available.</li><li>Change the antibiotic according to susceptibility results if bacteria are resistant using narrow-spectrum antibiotics if possible.</li></ul></li><li><strong>Ensure good practice in the management of long-term urinary catheters:</strong><ul><li>Regularly assess the need for catheterisation — urinary catheterisation should be carried out by appropriately trained healthcare workers using aseptic technique.</li><li>Do not routinely offer antibiotic prophylaxis to prevent catheter-associated UTIs when changing catheters in women with a long-term indwelling urinary catheter.<ul><li>Prophylaxis may be appropriate in certain cases for example history of UTI following catheter change — discuss with a specialist.</li></ul></li><li>Do not routinely treat catheter-associated asymptomatic bacteriuria.</li></ul></li></ul><!-- end field bf99f672-b5a6-4266-a7b5-a71b01013737 --><!-- end item 9bc4afd2-fbbb-4847-ba51-a71b010137ea -->","subChapters":[{"id":"eb63556c-3edc-584b-804b-a140ed74a19c","slug":"basis-for-recommendation-f8c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field e83204c6-aebc-4740-bb95-a71b0101373c --><h4>Basis for recommendation</h4><!-- end field e83204c6-aebc-4740-bb95-a71b0101373c -->","summary":null,"htmlStringContent":"<!-- begin item f8c093da-4cd2-43bb-a1f2-a71b0101373c --><!-- begin field 2d4a9912-c30b-404c-ae72-a71b0101373c --><p>The recommendations on the management of catheter associated UTI (CA-UTI) are based on the clinical guidelines <em>Healthcare-associated infections: prevention and control in primary and community care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2017c</a>], <em>Catheter associated urinary tract infections: antimicrobial prescribing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>], <em>Diagnosis of urinary tract infections (UTIs). Quick reference guide for primary care: for consultation and local adaptation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>], and <em>Urological infections</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">Johnston, 2017</a>].</p><h5>Urgent assessment</h5><p>Clinical guidelines from Public Health England (PHE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] and the National Institute for Health and Care Excellence (NICE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>] highlight the importance of prompt recognition and treatment of serious illness such as pyelonephritis and sepsis.</p><h5>Referral/seeking specialist advice</h5><p>The recommendations on when to refer/seek specialist advice on further management of CA-UTI are based on the NICE guidelines <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2017b</a>] and <em>Catheter associated urinary tract infections: antimicrobial prescribing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>].</p><ul><li>CA-UTIs are often polymicrobial and multiple-drug resistant [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>].</li></ul><h5>Self-care measures</h5><p>Recommendations on use of simple analgesia, maintaining adequate hydration and advice on prevention of further UTI are based on clinical guidance from PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] and NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>].</p><ul><li>NICE found no evidence to support the use of cranberry products and urine alkalinising agents in treatment of lower UTI [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>].</li></ul><h5>Change/removal of catheter</h5><p>The recommendation on considering removing or changing a urinary catheter when CA-UTI is suspected is based on the NICE clinical guideline <em>Catheter associated urinary tract infections: antimicrobial prescribing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>] and guidance from PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] and The European Association of Urology (EAU) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>].</p><ul><li>A urine sample complete with detailed clinical information should be sent for culture and sensitivities [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>].</li></ul><h5>Antibiotic treatment</h5><p>The recommendations on antibiotic choice and duration are from the NICE guideline <em>Catheter associated urinary tract infections: antimicrobial prescribing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>].</p><ul><li>Clinical guidance from PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>], EAU [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>] and NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>] agree on the need to take a urine culture prior to initiating antibiotics due to the wide variety of possible infecting organisms, potential for multi-organism infection and increased risk of antimicrobial resistance associated with CA-UTI.</li><li>A lower risk of resistance to the prescribed antibiotic is likely if it has not been used in the preceding 3 months, previous urine culture suggests susceptibility (but this was not used), and when used in younger people in areas where local epidemiology data suggest resistance is low. A higher risk of resistance is likely with recent use and in older people in long term care facilities [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>].</li></ul><h5>Advice on seeking review</h5><p>Guidance from PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] and NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018d</a>] advises that the woman should be advised to seek urgent medical review if symptoms worsen at any time or fail to improve within 48 hours of starting antibiotics.</p><ul><li>On review the possibility of alternative or serious diagnoses such as pyelonephritis or sepsis should be considered.</li></ul><h5>Follow up urine culture and susceptibility results </h5><ul><li>Guidance from NICE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>] and PHE [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">PHE, 2017</a>] recommends that choice of antibiotic is reviewed when culture results become available – antibiotic should be changed according to susceptibility results if bacteria are resistant, using narrow-spectrum antibiotics wherever possible.</li></ul><h5>Management of urinary catheters</h5><p>The recommendations on management of short-term or long-term (indwelling or intermittent) urinary catheters are based on clinical guidelines from NICE on <em>Healthcare Associated Infection</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2017c</a>] and international guidelines from the American Association of Urology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">AUA, 2014</a>] and the European Association of Urology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>].</p><ul><li>Do not use prophylactic antibiotics to prevent catheter-associated UTIs [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>] — seek specialist advice for recurrent CA-UTI.</li><li>Do not treat catheter-associated asymptomatic bacteriuria in general — the longer a catheter is in place, the more likely bacteriuria will be present.  Nearly all people who are catheterised will have bacteriuria after 1 month. Antibiotic treatment is not routinely needed for asymptomatic bacteriuria in non-pregnant people with a catheter [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">EAU, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urinary-tract-infection-lower-women/references/\">NICE, 2018c</a>].</li></ul><!-- end field 2d4a9912-c30b-404c-ae72-a71b0101373c --><!-- end item f8c093da-4cd2-43bb-a1f2-a71b0101373c -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}